clarithromycin has been researched along with Infections, Pneumococcal in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (20.00) | 18.2507 |
2000's | 21 (52.50) | 29.6817 |
2010's | 7 (17.50) | 24.3611 |
2020's | 4 (10.00) | 2.80 |
Authors | Studies |
---|---|
Bui, MH; Chu, DT; Elliott, RL; Ewing, PJ; Flamm, RK; Griesgraber, G; Henry, RF; Kim, K; Nilius, AM; Or, YS; Pireh, D; Plattner, JJ; Raney, PM | 1 |
Bui, MH; Chu, DT; Elliott, RL; Ewing, PJ; Flamm, RK; Griesgraber, G; Kramer, MJ; Nilius, AM; Or, YS; Plattner, JJ; Raney, PM | 1 |
Anderson, S; Barker, L; Burger, MT; Carroll, GL; Chu, DT; Desai, MC; Hiebert, C; Huh, K; Kidney, J; Langhorne, M; Lin, X; Plattner, JJ; Rico, AC; Seid, M; Shawar, R; Young, K | 1 |
Appelbaum, PC; Credito, KL; DeWasse, B; Kosowska-Shick, K; McGhee, P; Pankuch, GA | 1 |
Klugman, KP; Low, DE; Smith, AM; Wolter, N | 1 |
Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
Sugimoto, T; Suzuki, K; Tanikawa, T; Yamasaki, Y | 1 |
Adam, HJ; Alford, MA; Baxter, MR; Demczuk, W; Golden, AR; Karlowsky, JA; Martin, I; Mulvey, MR; Schellenberg, J; Zhanel, GG | 1 |
Agrawal, A; Ngwa, DN; Singh, SK | 1 |
Almeida, L; Dhillon-LaBrooy, A; Henriques-Normark, B; Lindenberg, M; Siegel, E; Sparwasser, T | 1 |
Adam, HJ; Baxter, M; Demczuk, W; Fear, T; Golden, AR; Karlowsky, JA; Martin, I; Zhanel, GG | 1 |
Adam, HJ; Baxter, MR; Demczuk, W; Gilmour, MW; Golden, AR; Hoban, DJ; Karlowsky, JA; Martin, I; Mulvey, MR; Nichol, KA; Zhanel, GG | 2 |
Aksoy, A; Arslan, S; Gacar, A; Genc, G; Guvenc, T; Koyuncu, M; Kurnaz, SC; Kutlar, G | 1 |
Bares, S; Guzman Vinasco, L; Sandkovsky, U | 1 |
Burgmann, H; Georgopoulos, A; Kollaritsch, H; Kundi, M; Paulke-Korinek, M; Rendi-Wagner, P; Vécsei, A | 1 |
Araj, GF; Awar, GN; Baban, TA; Kanj, SS; Naba, MR; Tabbarah, ZA | 1 |
Blondeau, JM; Drlica, K; Metzler, K | 1 |
Peetermans, WE; Van Kerkhoven, D; Verbist, L; Verhaegen, J | 1 |
Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
Arrieta, A; Gonzalez, G; Scharer, G; Singh, J; Vargas-Shiraishi, O; Zaldivar, F | 1 |
Itoh, Y; Kikuchi, K; Nakanishi, K; Nakao, S; Ohsaki, Y; Osanai, S; Saito, K; Sato, M; Tachibana, M; Takahashi, T; Toyoshima, E | 1 |
Kinzig-Schippers, M; Kolbert, M; Machka, K; Malerczyk, C; Shah, PM; Sörgel, F | 1 |
Buxbaum, A; Forsthuber, S; Georgopoulos, A; Graninger, W | 1 |
Ferguson, BJ | 1 |
Amyes, SG; Dobay, O; Hajdú, E; Knausz, M; Nagy, E; Rozgonyi, F | 1 |
Doern, GV | 1 |
Adelman, MH; Chiou, CC; Klugman, KP; Lavin, B; Paladino, JA; Patel, M; Schentag, JJ; Wilton, GJ; Yu, VL | 1 |
Lonks, JR; Medeiros, AA | 1 |
Cimochowski, CR; Faiella, JA; Girard, AE | 1 |
Alper, CM; Bluestone, CD; Doyle, WJ; Seroky, JT | 1 |
McLinn, S; Williams, D | 1 |
Brookings, E; Gray, B; Swiatlo, E; Waites, K | 1 |
Hill, SL; Johnson, MM; Piddock, LJ | 1 |
Gotfried, MH | 1 |
Al Rasheed, AM; Elbashier, AM; Osoba, AO; Shibl, AM | 1 |
Benjamin, W; Crain, M; Edwards, K; Gray, B; Johnson, C; Waites, K | 1 |
Cohen, MS; Gilligan, P; Kelley, MA; Weber, DJ | 1 |
Baumgartner, JD; Bochud, PY; Calandra, T; Moreillon, P; Yersin, B | 1 |
Schooley, S; Stein, GE | 1 |
2 review(s) available for clarithromycin and Infections, Pneumococcal
Article | Year |
---|---|
Macrolide and ketolide resistance with Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Humans; Ketolides; Macrolides; Membrane Proteins; Pneumococcal Infections; Streptococcus pneumoniae | 2006 |
Comparison of bacteriologic eradication of Streptococcus pneumoniae by clarithromycin and reports of increased antimicrobial resistance.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Humans; Pneumococcal Infections; Streptococcus pneumoniae | 2000 |
2 trial(s) available for clarithromycin and Infections, Pneumococcal
Article | Year |
---|---|
Serum bactericidal activity of gemifloxacin versus clarithromycin against Streptococcus pneumoniae with different susceptibility to quinolones.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Clarithromycin; Cross-Over Studies; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Gemifloxacin; Humans; Male; Middle Aged; Naphthyridines; Pneumococcal Infections; Quinolones; Streptococcus pneumoniae | 2004 |
Serum bactericidal activity of extended-release clarithromycin against macrolide-resistant strains of Streptococcus pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Delayed-Action Preparations; Drug Resistance; Genes, Bacterial; Humans; Male; Middle Aged; Pneumococcal Infections; Serum Bactericidal Test; Streptococcus pneumoniae; Time Factors | 2002 |
36 other study(ies) available for clarithromycin and Infections, Pneumococcal
Article | Year |
---|---|
Anhydrolide macrolides. 1. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbamate erythromycin A analogues.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Clarithromycin; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Mice; Molecular Conformation; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Virginiamycin | 1998 |
Anhydrolide macrolides. 2. Synthesis and antibacterial activity of 2,3-anhydro-6-O-methyl 11,12-carbazate erythromycin A analogues.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Lincosamides; Macrolides; Mice; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Virginiamycin | 1998 |
Synthesis and antibacterial activity of novel C12 vinyl ketolides.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Drug Resistance, Bacterial; Enterococcus faecalis; Haemophilus Infections; Haemophilus influenzae; Half-Life; Ketolides; Lung Diseases; Male; Microbial Sensitivity Tests; Pneumococcal Infections; Rats; Rats, Sprague-Dawley; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Vinyl Compounds | 2006 |
Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.
Topics: Amidohydrolases; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Peptides; Pneumococcal Infections; Species Specificity; Streptococcus pneumoniae; Time Factors | 2007 |
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Drug Resistance, Bacterial; Genotype; Humans; Ketolides; Methyltransferases; Microbial Sensitivity Tests; Mutation; Phenotype; Pneumococcal Infections; Ribosomal Proteins; Streptococcus pneumoniae | 2007 |
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
Synthesis and structure-activity relationship of a novel class of 15-membered macrolide antibiotics known as '11a-azalides'.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Structure-Activity Relationship | 2012 |
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-2020.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Ceftriaxone; Chloramphenicol; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
C-Reactive Protein-Based Strategy to Reduce Antibiotic Dosing for the Treatment of Pneumococcal Infection.
Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Clarithromycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Immunity, Innate; Male; Mice; Mice, Inbred C57BL; Mutagenesis, Site-Directed; Mutation, Missense; Pneumococcal Infections; Recombinant Proteins | 2020 |
Clarithromycin impairs tissue-resident memory and Th17 responses to macrolide-resistant Streptococcus pneumoniae infections.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Host-Pathogen Interactions; Humans; Immunologic Memory; Lymphocyte Activation; Macrolides; MAP Kinase Signaling System; Memory T Cells; Pneumococcal Infections; Streptococcus pneumoniae; Th17 Cells | 2021 |
Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Canada; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Middle Aged; Pneumococcal Infections; Pneumococcal Vaccines; Serogroup; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; Vaccines, Conjugate; Young Adult | 2021 |
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Canada; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Risk Factors; Streptococcus pneumoniae; Young Adult | 2018 |
Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Canada; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Serogroup; Serotyping; Streptococcus pneumoniae; Vancomycin; Young Adult | 2018 |
Does systemic clarithromycin therapy have an inhibitory effect on tympanosclerosis? An experimental animal study.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Linear Models; Middle Ear Ventilation; Myringosclerosis; Otitis Media; Pneumococcal Infections; Random Allocation; Rats; Streptococcus pneumoniae; Tympanic Membrane | 2015 |
Acute suppurative parotitis caused by Streptococcus pneumoniae in an HIV-infected man.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Clarithromycin; Contrast Media; Doxycycline; HIV Infections; Humans; Male; Parotid Gland; Parotitis; Pneumococcal Infections; Radiographic Image Enhancement; Streptococcus pneumoniae; Tomography, X-Ray Computed | 2015 |
National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases.
Topics: Animals; Anti-Bacterial Agents; Austria; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Health Policy; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Immunization Programs; Incidence; Infant; Male; Meningitis, Pneumococcal; Pneumococcal Infections; Pneumococcal Vaccines; Serotyping; Streptococcus pneumoniae; Vaccination | 2009 |
Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lebanon; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 2010 |
Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Attention; Azithromycin; Canada; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests; Mutation; Pneumococcal Infections; Streptococcus pneumoniae | 2013 |
Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; beta-Lactams; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Pneumococcal Infections; Retrospective Studies; Treatment Failure | 2003 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
Systemic inflammatory responses in children with acute otitis media due to Streptococcus pneumoniae and the impact of treatment with clarithromycin.
Topics: Biomarkers; Case-Control Studies; Child, Preschool; Clarithromycin; Follow-Up Studies; Humans; Infant; Inflammation; Interleukin-1; Interleukin-6; Interleukin-8; Interleukins; Otitis Media with Effusion; Pilot Projects; Pneumococcal Infections; Time Factors; Tumor Necrosis Factor-alpha | 2003 |
Alterations in penicillin binding protein gene of Streptococcus pneumoniae and their correlation with susceptibility patterns.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carrier Proteins; Clarithromycin; Drug Resistance, Bacterial; Genes, Bacterial; Hexosyltransferases; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumococcal Infections; Streptococcus pneumoniae; Thienamycins | 2003 |
Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in Austria.
Topics: Anti-Bacterial Agents; Austria; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Pneumococcal Vaccines; Population Surveillance; Serotyping; Streptococcus pneumoniae; Vaccination | 2004 |
Is it spontaneous resolution or macrolide efficacy?
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease; Clarithromycin; Female; Gram-Negative Bacterial Infections; Humans; Infant; Macrolides; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Nasopharynx; Otitis Media with Effusion; Pneumococcal Infections; Rhinitis; Sinusitis; Streptococcus pneumoniae | 2004 |
The relationship between serotypes and PFGE genotypes in isolates of Streptococcus pneumoniae from Hungary.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Hungary; Microbial Sensitivity Tests; Penicillins; Phenotype; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae | 2005 |
Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
Topics: Anti-Bacterial Agents; Area Under Curve; Azithromycin; Bacteremia; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Failure | 2007 |
High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I.
Topics: Adult; Aged; Bacteremia; Child; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumococcal Infections; Rhode Island; Streptococcus pneumoniae | 1993 |
The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Endocarditis, Bacterial; Erythromycin; Female; Gerbillinae; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Otitis Media; Pneumococcal Infections; Pneumonia; Rats; Roxithromycin; Streptococcal Infections; Streptococcus pyogenes | 1993 |
Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Chinchilla; Clarithromycin; Microbial Sensitivity Tests; Otitis Media with Effusion; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae | 1996 |
Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Child; Clarithromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Incidence; Microbial Sensitivity Tests; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 1996 |
In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment.
Topics: Administration, Oral; Adult; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Child; Clarithromycin; Clindamycin; Culture Media; Humans; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents.
Topics: Anti-Bacterial Agents; Azithromycin; Carbon Dioxide; Clarithromycin; Colony Count, Microbial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Hydrogen-Ion Concentration; Lung Diseases, Obstructive; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Sputum; Streptococcus pneumoniae | 1999 |
Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia.
Topics: Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Clarithromycin; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Saudi Arabia; Streptococcus pneumoniae | 2000 |
Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children.
Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Humans; Methyltransferases; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bacteremia; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Failure | 2000 |
Breakthrough Streptococcus pneumoniae meningitis during clarithromycin therapy for acute otitis media.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Clarithromycin; Female; Humans; Meningitis, Pneumococcal; Otitis Media; Pneumococcal Infections; Streptococcal Infections; Streptococcus pneumoniae | 2001 |